Details for New Drug Application (NDA): 017543
✉ Email this page to a colleague
NDA 017543 describes LUDIOMIL, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the LUDIOMIL profile page.
The generic ingredient in LUDIOMIL is maprotiline hydrochloride. There are three drug master file entries for this compound. Additional details are available on the maprotiline hydrochloride profile page.
The generic ingredient in LUDIOMIL is maprotiline hydrochloride. There are three drug master file entries for this compound. Additional details are available on the maprotiline hydrochloride profile page.
Summary for 017543
| Tradename: | LUDIOMIL |
| Applicant: | Novartis |
| Ingredient: | maprotiline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017543
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
| Approval Date: | Sep 30, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
